Evofem Biosciences, Inc. (EVFM): R&D Expense
$1.84M
Year ended 2024-12-31
-61.8%
3-year compound annual growth
-39.2%
5-year compound annual growth
-9.8%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $1.84M | -37.2% | 2025-03-24, From 2024-01-01 |
| 2023-12-31 | $2.94M | -88.3% | 2025-03-24, From 2023-01-01 |
| 2022-12-31 | $25.03M | -24.4% | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | $33.13M | +94.3% | 2023-04-27, From 2021-01-01 |
| 2020-12-31 | $17.05M | -23.3% | 2022-03-10, From 2020-01-01 |
| 2019-12-31 | $22.23M | -48.8% | 2021-03-04, From 2019-01-01 |
| 2018-12-31 | $43.41M | +84.4% | 2020-03-12, From 2018-01-01 |
| 2017-12-31 | $23.54M | +257.8% | 2019-03-01, From 2017-01-01 |
| 2016-12-31 | $6.58M | -80.9% | 2018-02-26, From 2016-01-01 |
| 2015-12-31 | $34.41M | +564.9% | 2018-02-26, From 2015-01-01 |
| 2014-12-31 | $5.17M | -54.8% | 2017-03-23, From 2014-01-01 |
| 2013-12-31 | $11.45M | n/a | 2016-03-29, From 2013-01-01 |